Themis Medicare

₹100.58As of Sun 8 Nov 2026, 12:00 UTC

NSE:THEMISMEDHealthcare

Country India

PE (Fwd) 1,233

TSR 10Y CAGR 4.13%

Div yield 0.50%

ROE —

Drug Manufacturers (Specialty & Generic)

Beta (5Y) 0.67

PE TTM 810.7

TSR TTM (18.70%)

Mkt cap ₹9.558B

ROIC —

SE Grade™

—

Value

Quality

Moat

—

1Y Price

Reference

₹112

11.57%

(88.11%)

Price above Reference Value

TTM

FYE 31 Mar INR

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

10Y

Peers

3.422

Revenue₹B

—

3.946

3.543

3.818

4.055

3.422

3.390

(3.50%)

(15.60)

Revenue growth%

—

(10.21)

7.74

6.22

(15.60)

(0.93)

(1.99)

—

61.46

Gross margin%

—

61.77

65.88

63.62

66.88

61.46

61.59

63.62

(2.90)

Operating margin%

—

21.83

16.07

10.28

9.65

(2.90)

(3.08)

10.28

0.33

Net margin%

—

18.47

16.06

11.40

7.36

0.33

0.26

11.40

810.7

P/E ratio (avg)x

—

9.057

18.93

41.03

75.39

937.0

1,056

41.03

—

EV/EBITx

—

7.661

18.91

45.48

57.50

—

32.20

—

FCF yield (avg)%

—

FCF margin%

—

FCF / Net incomex

—

ROIC%

—

Return on equity%

—

Return on assets%

—

0.12

EPS₹

—

7.91

6.17

4.72

3.24

0.12

0.10

(64.61%)

—

(96.17)

EPS growth%

—

(21.93)

(23.53)

(31.46)

(96.17)

(23.24)

(27.50)

—

Bookvalue per sh₹

—

FCF per share₹

—

0.50

Dividend per sh₹

—

0.50

0.51

—

0.50

Div yield (avg)%

—

0.70

0.43

0.26

0.20

0.43

0.51

0.43

416.67

Payout ratio%

—

6.32

8.10

10.59

15.43

416.67

539.15

10.59

92.20

Shares (diluted)M

—

92.18

92.21

92.20

◌92.20

0.01%

0.01

Buyback yield%

—

(0.01)

(0.03)

(0.01)

0.01

◌—

(0.01)

—

D/E ratiox

—

9.274

Enterprise value₹B

—

6.601

10.77

17.86

22.49

10.72

9.274

12.88%

—

LT debt₹M

—

Peers (US$99.12M)

Cap (US$)

Bajaj HealthCare…

111.5M

49.46x

Lincoln Pharmaceutical…

108.5M

10.50x

Anuh Pharma Limited

88.22M

17.20x

Pak Fah Yeow Internati…

99.38M

7.873x

Capital

TTM

10Y

Leveragex

—

EBIT/Intx

(1.116)

5.147

Own earn%

—

Sh yield%

0.51

0.33

Owners

Insiders/Inst%

35.65

1.56

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

5/5

Revenue growth years

2/4

EPS growth years

0/4

Dividend streakyrs

Op margin range%

−3–22

$1 testx

—

Incr. ROIC%

—

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally.

Growth vs revenue

Latest

Trend

4Y CAGR

Rel growth

Revenue

₹3.422B

(3.50%)

1.00×

Cost of revenue

₹1.319B

(3.31%)

1.01×

Operating expenses

₹2.203B

8.74%

1.61×

Revenue by region

No breakdown available

Reinvestment returns

No breakdown available